News - Page 33 - Psychedelic Alpha

Read more about the article Small Pharma Reports Fiscal First Quarter 2024 Highlights

Small Pharma Reports Fiscal First Quarter 2024 Highlights

Post published:July 28, 2023
Post category:Press Release

Read more about the article Optimi Health Announces Receipt of Purported Termination Notice

Optimi Health Announces Receipt of Purported Termination Notice

Post published:July 27, 2023
Post category:Press Release

Read more about the article A Call for Clarity in Psychedelic Discourse

A Call for Clarity in Psychedelic Discourse

Post published:July 25, 2023
Post category:Opinions

Read more about the article First clinical study results of psilocybin treatment in anorexia nervosa published in Nature Medicine

First clinical study results of psilocybin treatment in anorexia nervosa published in Nature Medicine

Post published:July 25, 2023
Post category:Press Release

Read more about the article FILAMENT HEALTH ANNOUNCES UPSIZING AND CLOSING OF $2,500,000 NON-BROKERED PRIVATE PLACEMENT FINANCING

FILAMENT HEALTH ANNOUNCES UPSIZING AND CLOSING OF $2,500,000 NON-BROKERED PRIVATE PLACEMENT FINANCING

Post published:July 24, 2023
Post category:Press Release

Read more about the article Bright Minds Biosciences Announces Positive Topline Data for its First-in-Human Phase 1 Study of Lead Compound, BMB-101

Bright Minds Biosciences Announces Positive Topline Data for its First-in-Human Phase 1 Study of Lead Compound, BMB-101

Post published:July 20, 2023
Post category:Press Release

Read more about the article FILAMENT HEALTH CORP. ANNOUNCES NON-BROKERED PRIVATE PLACEMENT UNIT OFFERING OF UP TO C$2,000,000

FILAMENT HEALTH CORP. ANNOUNCES NON-BROKERED PRIVATE PLACEMENT UNIT OFFERING OF UP TO C$2,000,000

Post published:July 19, 2023
Post category:Press Release

Read more about the article Non-Hallucinogenic Trip Reports: Searching for the Tabernanthalog Tasters

Non-Hallucinogenic Trip Reports: Searching for the Tabernanthalog Tasters

Post published:July 19, 2023
Post category:Analysis

Read more about the article PharmaTher Announces Positive Research Results for PharmaPatch™ with N,N-dimethyltryptamine (DMT) and Strategic Investment into Sairiyo Therapeutics

PharmaTher Announces Positive Research Results for PharmaPatch™ with N,N-dimethyltryptamine (DMT) and Strategic Investment into Sairiyo Therapeutics

Post published:July 18, 2023
Post category:Press Release

Read more about the article Clearmind Medicine Announces Share-Based Payment for the Company’s Consultants

Clearmind Medicine Announces Share-Based Payment for the Company’s Consultants

Post published:July 18, 2023
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.